1. Home
  2. JJSF vs DNTH Comparison

JJSF vs DNTH Comparison

Compare JJSF & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • DNTH
  • Stock Information
  • Founded
  • JJSF 1971
  • DNTH 2015
  • Country
  • JJSF United States
  • DNTH United States
  • Employees
  • JJSF N/A
  • DNTH N/A
  • Industry
  • JJSF Specialty Foods
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • JJSF Consumer Staples
  • DNTH Health Care
  • Exchange
  • JJSF Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • JJSF 1.7B
  • DNTH 1.8B
  • IPO Year
  • JJSF N/A
  • DNTH N/A
  • Fundamental
  • Price
  • JJSF $90.98
  • DNTH $43.80
  • Analyst Decision
  • JJSF Strong Buy
  • DNTH Strong Buy
  • Analyst Count
  • JJSF 3
  • DNTH 10
  • Target Price
  • JJSF $138.33
  • DNTH $68.00
  • AVG Volume (30 Days)
  • JJSF 293.6K
  • DNTH 737.7K
  • Earning Date
  • JJSF 11-17-2025
  • DNTH 11-05-2025
  • Dividend Yield
  • JJSF 3.50%
  • DNTH N/A
  • EPS Growth
  • JJSF N/A
  • DNTH N/A
  • EPS
  • JJSF 3.36
  • DNTH N/A
  • Revenue
  • JJSF $1,583,233,000.00
  • DNTH $3,078,000.00
  • Revenue This Year
  • JJSF $5.42
  • DNTH N/A
  • Revenue Next Year
  • JJSF $2.64
  • DNTH N/A
  • P/E Ratio
  • JJSF $27.18
  • DNTH N/A
  • Revenue Growth
  • JJSF 0.54
  • DNTH N/A
  • 52 Week Low
  • JJSF $80.67
  • DNTH $13.37
  • 52 Week High
  • JJSF $176.77
  • DNTH $44.27
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 57.39
  • DNTH 70.39
  • Support Level
  • JJSF $88.34
  • DNTH $39.82
  • Resistance Level
  • JJSF $92.48
  • DNTH $43.34
  • Average True Range (ATR)
  • JJSF 2.99
  • DNTH 2.64
  • MACD
  • JJSF 1.33
  • DNTH 0.63
  • Stochastic Oscillator
  • JJSF 89.72
  • DNTH 94.63

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: